Home Nursing Diabetes Mellitus: Pathophysiology, Diagnosis, and Pharmacological Management

Diabetes Mellitus: Pathophysiology, Diagnosis, and Pharmacological Management

Diabetes Mellitus: Pathophysiology, Diagnosis, and Pharmacological Management
Essay (any type) Nursing 1053 words 4 pages 04.02.2026
Download: 58
Writer avatar
Alison B.
I am a diligent and proficient tutor in diverse fields
Highlights
Nursing leadership and development Patient care and safety Chronic disease management Patient education
89.57%
On-time delivery
5.0
Reviews: 2751
  • Tailored to your requirements
  • Deadlines from 3 hours
  • Easy Refund Policy
Hire writer

Diabetes Mellitus, a condition that borrows heavily from genetics and lifestyle patterns, is a highly prevalent metabolic disorder that is among the leading causes of disability, morbidity, and mortality. It is primarily characterized by elevated glucose levels caused by impaired metabolism of these molecules. The hyperglycemia is induced by insulin deficiency and resistance. During diagnosis, high blood concentration marks Diabetes Mellitus. It can be treated using medications that restore proper insulin production and sensitivity in peripheral tissues. Notably, understanding the pathophysiology, diagnosis, and treatment of diabetes Mellitus is no longer an option in the 21st Century.

Pathophysiology of Diabetes Mellitus

Regarding pathophysiology, Diabetes Mellitus is a chronic metabolic disorder caused by insulin deficiency and resistance. Insulin is a vital hormone that regulates blood glucose levels (Banday et al., 2020). When the glucose levels are high, the beta cells in the pancreas are stimulated to secrete insulin released into the bloodstream. The release allows glucose utilization in target organs such as the muscle cells, adipose tissue, and the liver as energy or for storage (Banday et al., 2020). However, when the beta cells are dysfunctional, signaling insulin production does not yield adequate insulin levels to regulate blood glucose concentration effectively. Consequently, glucose concentration in the bloodstream is persistently elevated, leading to organ failure and the onset of Diabetes Mellitus. This disorder also develops when the target cells, such as the kidney and adipose tissue for glucose utilization, are unresponsive to insulin. Such resistance causes hyperglycemia, which triggers increased insulin secretion, causing the hormone to flood the bloodstream without causing the desired action. As the demand for insulin heightens, the pancreas loses its ability to produce the hormone (Banday et al., 2020). A person can have insulin deficiency and resistance, diminishing normal glucose metabolism and triggering Diabetes Mellitus. Elevated plasma concentrations of glucose for prolonged periods lead to microvascular and macrovascular complications that lead to morbidity and mortality in patients with diabetes mellitus. This condition is also associated with retinopathy, which ultimately leads to blindness, cell death in the kidney that causes renal failure, and increased risk for cardiovascular and heart diseases. These adverse effects of Diabetes Mellitus are the focus of nursing assessment.

The pathophysiology of Diabetes Mellitus is triggered by risk factors such as genetic predisposition, low physical activity, and unhealthy dietary habits. Some individuals with blood relatives diagnosed with Diabetes Mellitus carry genetic variants that make them susceptible to this disorder. The genetic variants support intermediate mechanisms for diabetes, such as impaired insulin production and processing, increasing the potential for the individual to develop this complication (Ojo et al., 2023). Additionally, low physical activity lowers glucose utilization and insulin sensitivity, leading to diabetes. A sedentary lifestyle does not support muscle contractions that promote glucose metabolism and increase the intra-abdominal fat that facilitates insulin resistance. Poor dietary habits increase blood glucose concentration and diminish its utilization, causing a surplus that triggers Diabetes Mellitus. These risk factors are the focus of intervention to enhance insulin production and sensitivity in target cells.

Put your paper in expert hands

Get a custom essay written to your exact requirements – researched, structured, and delivered on time.

Write my essay

Diagnosis of Diabetes Mellitus

Additionally, a diagnosis of Diabetes Mellitus is mostly confirmed using the hemoglobin A1C test. The test entails screening the patient's blood, allowing the clinician to assess the client's glycemic levels. A healthy patient's mean glucose level is between 70 and 100 milligrams per deciliter, while glucose concentration is between 3.9 and 5.5 millimoles per liter (Ojo et al., 2023). Thus, when the HbA1C test yields values that surpass this range, the clinician can confidently diagnose the patient with Diabetes Mellitus. Most importantly, this test provides baseline values from which the patient’s recovery can be tracked after intervention.

Treatment

Pharmacological treatment through nursing care is an effective intervention for Diabetes Mellitus. There exist medications that effectively correct insulin deficiency and resistance and normalize blood glucose levels. These medications include sulfonylureas such as chlorpropamide, glyburide, glimepiride, glipizide, tolazamide, and tolbutamide that are metabolized in the liver to trigger pancreatic beta cells to secrete insulin and correct hyperglycemia (Ojo et al., 2023). More than that, sulfonylureas enhance insulin sensitivity in peripheral tissues and inhibit glucose production as this hormone increases blood glucose levels and reduces insulin clearance in the hepatic pathway. It is important to note that once a nurse administers these medications, the patient's insulin secretion will increase with little regard for the glucose concentration.

Additionally, meglitinides such as repaglinide and nateglinide are fast-acting medications that stimulate the pancreas to produce insulin based on blood glucose levels (Ojo et al., 2023). Thus, it is especially effective if administered to counter postprandial hyperglycemia, alleviating Diabetes Mellitus symptoms. Metformin is another essential medication for diabetic patients as it reduces insulin resistance by restoring insulin sensitivity in the target peripheral organs. Metformin induces these outcomes by lowering free fatty acids, triglycerides, and glucose in the blood plasma by increasing gut glucose utilization (Ojo et al., 2023). While performing these actions, Metformin does not alter insulin production, allowing the body to utilize insulin already circulating in the blood. Given the unique effects of these medications, they are combined to produce the desirable health outcomes. Beyond medication administration, nurses provide patients with education on prescribed drugs and required lifestyle modifications for sustained recovery. They also monitor the patient’s glucose levels to ensure immediate intervention when an issue arises.

In conclusion, Diabetes Mellitus is a condition with severe complications, making it a health concern. It is mainly caused by insulin deficiency and resistance, impairing glucose utilization to produce energy for the skeletal muscle cells, liver, and adipose tissue. Diagnosis is established through the hemoglobin A1C test, which showcases the glucose levels. It can be treated through medications such as Metformin and sulfonylureas. However, there is a need for a more informed public that is equipped with the correct information about the importance of being more sensitive to what they take into their bodies. Additionally, the government should enforce more policies to protect citizens against rogue manufacturers with little regard for health and declare diabetes a national threat.

Offload drafts to field expert

Our writers can refine your work for better clarity, flow, and higher originality in 3+ hours.

Match with writer
350+ subject experts ready to take on your order

References

  1. Banday, M., Sameer, A., & Nissar, S. (2020). Pathophysiology of diabetes: an overview. Avicenna Journal of Medicine, 10(4), 174–188. https://doi.org/10.4103/ajm.ajm_53_20
  2. Ojo, O. A., Ibrahim, H. S., Rotimi, D. E., Ogunlakin, A. D., & Ojo, A. B. (2023). Diabetes mellitus: From molecular mechanism to pathophysiology and pharmacology. Medicine in Novel Technology and Devices, 19, 100247. https://doi.org/10.1016/j.medntd.2023.100247